Jacquelyn Powers

1.5k total citations
27 papers, 458 citations indexed

About

Jacquelyn Powers is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jacquelyn Powers has authored 27 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Jacquelyn Powers's work include BRCA gene mutations in cancer (17 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Genomics and Diagnostics (8 papers). Jacquelyn Powers is often cited by papers focused on BRCA gene mutations in cancer (17 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Genomics and Diagnostics (8 papers). Jacquelyn Powers collaborates with scholars based in United States and Australia. Jacquelyn Powers's co-authors include Susan M. Domchek, Katherine L. Nathanson, Jill E. Stopfer, Kara N. Maxwell, Angela R. Bradbury, Jessica M. Long, Bradley Wubbenhorst, Jiajun Zhu, Kurt D’Andrea and Bradley Garman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Jacquelyn Powers

22 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacquelyn Powers United States 11 324 156 139 110 108 27 458
Jacqueline Mersch United States 3 333 1.0× 148 0.9× 173 1.2× 123 1.1× 185 1.7× 9 544
Jeanna McCuaig Canada 14 320 1.0× 139 0.9× 158 1.1× 76 0.7× 103 1.0× 39 490
Julie Erlichman United States 8 279 0.9× 103 0.7× 102 0.7× 69 0.6× 96 0.9× 9 382
Anne‐Bine Skytte Denmark 14 243 0.8× 109 0.7× 94 0.7× 75 0.7× 154 1.4× 40 506
Kimberley Hill Canada 12 266 0.8× 199 1.3× 150 1.1× 127 1.2× 42 0.4× 14 540
Gemma Llort Spain 14 435 1.3× 161 1.0× 149 1.1× 144 1.3× 314 2.9× 32 638
Zoe Kemp United Kingdom 12 316 1.0× 148 0.9× 258 1.9× 179 1.6× 225 2.1× 27 580
Eli Marie Grindedal Norway 10 196 0.6× 138 0.9× 161 1.2× 208 1.9× 102 0.9× 17 405
B.A.M. Heemskerk-Gerritsen Netherlands 8 331 1.0× 191 1.2× 125 0.9× 49 0.4× 79 0.7× 13 440
Muriel A. Adank Netherlands 12 321 1.0× 113 0.7× 111 0.8× 84 0.8× 136 1.3× 32 584

Countries citing papers authored by Jacquelyn Powers

Since Specialization
Citations

This map shows the geographic impact of Jacquelyn Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacquelyn Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacquelyn Powers more than expected).

Fields of papers citing papers by Jacquelyn Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacquelyn Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacquelyn Powers. The network helps show where Jacquelyn Powers may publish in the future.

Co-authorship network of co-authors of Jacquelyn Powers

This figure shows the co-authorship network connecting the top 25 collaborators of Jacquelyn Powers. A scholar is included among the top collaborators of Jacquelyn Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacquelyn Powers. Jacquelyn Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maxwell, Kara N., Katherine L. Nathanson, Stephen Bagley, et al.. (2025). Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort. Journal of Medical Genetics. 62(11). 720–723.
2.
McKenna, Danielle, Anton Safonov, Anh N. Le, et al.. (2024). Clinical management of TP53 mosaic variants found on germline genetic testing. Cancer Genetics. 284-285. 43–47. 5 indexed citations
3.
Le, Anh N., Jacquelyn Powers, Kristin Zelley, et al.. (2023). Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome. Cancer Prevention Research. 16(9). 507–512. 3 indexed citations
4.
McKenna, Danielle, Jacquelyn Powers, Jamie Brower, et al.. (2022). Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers. Journal of Genetic Counseling. 32(2). 342–350.
5.
Long, Jessica M., Jacquelyn Powers, & Bryson W. Katona. (2021). Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon. Gastrointestinal Endoscopy Clinics of North America. 32(1). 95–112. 2 indexed citations
6.
Lee, Daniel J., Ryan Hausler, Anh N. Le, et al.. (2021). Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. European Urology. 81(6). 559–567. 21 indexed citations
7.
Bradbury, Angela R., Brian L. Egleston, Linda Patrick‐Miller, et al.. (2020). Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients. Clinical Genetics. 97(4). 601–609. 8 indexed citations
8.
Le, Anh N., Joanna Harton, Jacquelyn Powers, et al.. (2020). Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Breast Cancer Research and Treatment. 181(1). 181–188. 39 indexed citations
9.
Katona, Bryson W., Jacquelyn Powers, Danielle McKenna, et al.. (2020). Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome. The American Journal of Gastroenterology. 115(12). 2095–2097. 12 indexed citations
10.
Powers, Jacquelyn, et al.. (2019). Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice. Current Treatment Options in Gastroenterology. 17(4). 636–649. 7 indexed citations
11.
Gaieski, Jill B., Linda Patrick‐Miller, Brian L. Egleston, et al.. (2019). Research participants’ experiences with return of genetic research results and preferences for web‐based alternatives. Molecular Genetics & Genomic Medicine. 7(9). e898–e898. 20 indexed citations
12.
Powers, Jacquelyn, et al.. (2019). Genetic counseling and oncology: proposed approaches for collaborative care delivery.. PubMed. 26(5 Suppl 2). 57–59. 7 indexed citations
13.
Cheng, Heather H., Jacquelyn Powers, Kerry Schaffer, & Oliver Sartor. (2018). Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer. American Society of Clinical Oncology Educational Book. 38(38). 372–381. 21 indexed citations
14.
Bradbury, Angela R., Jill B. Gaieski, Brian L. Egleston, et al.. (2018). Interest in and outcomes with web-based education for return of genetic research results for inherited susceptibility to breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1531–1531.
15.
Bradbury, Angela R., Linda Patrick‐Miller, Brian L. Egleston, et al.. (2015). Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genetics in Medicine. 18(1). 25–33. 46 indexed citations
16.
Maxwell, Kara N., Bradley Wubbenhorst, Kurt D’Andrea, et al.. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. Genetics in Medicine. 17(8). 630–638. 106 indexed citations
17.
Maxwell, Kara N., Bradley Wubbenhorst, Bradley Garman, et al.. (2014). Prevalence of mutations in a panel of breast cancer susceptibility genes in patients with early onset breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 1510–1510. 1 indexed citations
18.
Domchek, Susan M., Komal Jhaveri, Sujata Patil, et al.. (2012). Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer. Cancer. 119(7). 1344–1348. 40 indexed citations
19.
Cohen, Justine V., Laura Chiel, Jill E. Stopfer, et al.. (2011). Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy. Familial Cancer. 11(1). 69–75. 44 indexed citations
20.
Domchek, Susan M., Mia M. Gaudet, Jill E. Stopfer, et al.. (2009). Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2. Breast Cancer Research and Treatment. 119(2). 409–414. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026